Encorafenib and its Impurities
Encorafenib (trade name Braftovi) is a drug for the treatment of certain melanomas. it is a kinase inhibitor used to treat unresectable or metastatic melanoma with specific mutations. Reference standards of Encorafenib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
tert-Butyl (5-chloro-2-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)carbamate
tert-Butyl (5-chloro-2-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)carbamate
Catalogue No.:PA 05 1941010
CAS :
1269440-69-8
Molecular Formula : C17H24BClFNO4
Molecular Weight : 371.64
Methyl (R)-(1-((4-(3-iodo-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate
Methyl (R)-(1-((4-(3-iodo-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate
Catalogue No.:PA 05 1941011
CAS :
1269440-61-0
Molecular Formula : C15H21IN6O2
Molecular Weight : 444.28
Methyl (R)-(1-((4-(3-(3-amino-5-chloro-2-fluorophenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate
Methyl (R)-(1-((4-(3-(3-amino-5-chloro-2-fluorophenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate
Catalogue No.:PA 05 1941012
CAS :
NA
Molecular Formula : C21H25ClFN7O2
Molecular Weight : 461.93
Methyl (S)-(1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)(nitroso)amino)propan-2-yl)carbamate
Methyl (S)-(1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)(nitroso)amino)propan-2-yl)carbamate
Catalogue No.:PA 05 1941013
CAS :
NA
Molecular Formula : C22H26ClFN8O5S
Molecular Weight : 569.01

